Role of Inflammation in Diabetic Retinopathy
Open accessThe DOI matches its Crossref record; 248 of the 249 references it cites were found in a registry or an index.
Abstract
Diabetic retinopathy is a common complication of diabetes and remains the leading cause of blindness among the working-age population. For decades, diabetic retinopathy was considered only a microvascular complication, but the retinal microvasculature is intimately associated with and governed by neurons and glia, which are affected even prior to clinically detectable vascular lesions. While progress has been made to improve the vascular alterations, there is still no treatment to counteract the early neuro-glial perturbations in diabetic retinopathy. Diabetes is a complex metabolic disorder, characterized by chronic hyperglycemia along with dyslipidemia, hypoinsulinemia and hypertension. Increasing evidence points to inflammation as one key player in diabetes-associated retinal perturbations, however, the exact underlying molecular mechanisms are not yet fully understood. Interlinked molecular pathways, such as oxidative stress, formation of advanced glycation end-products and increased expression of vascular endothelial growth factor have received a lot of attention as they all contribute to the inflammatory response. In the current review, we focus on the involvement of inflammation in the pathophysiology of diabetic retinopathy with special emphasis on the functional relationships between glial cells and neurons. Finally, we summarize recent advances using novel targets to inhibit inflammation in diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and this might explain the difference in rates of intraocular inflammation between eyes with diabetic retinopathy and those with AMD, despite being treated with the same vector and concentration.”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inflammatory processes are known to be integral in the pathogenesis of diabetic retinopathy,82”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rajamani, U., & Jialal, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/790902 · Cited by 114
RetractedInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Wh n ot resolved in a timely fashion the typically b nefici l eff ct of inflammation is lost a d dramatic consequence ensues [43].”
Background(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Reactive astrocytes: cellular and molecular cues to biological function
Ridet, J. L., Privat, A., Malhotra, S. K., & Gage, F. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01139-9 · Cited by 1,766
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Research works printed but not linked: 1
- (2017, October 30). Allegro Ophthalmics Announces Positive Topline Results from Del Mar Phase 2b Trial Evaluating Luminate® in Patients with Diabetic Macular Edema. Available online: http://www.allegroeye.com/press.
Cited by
Items 201–300 of 749
The uPAR System as a Potential Therapeutic Target in the Diseased Eye
Cammalleri, M., Monte, M. D., Pavone, V., Rosa, M. D., Rusciano, D., & Bagnoli, P. (2019) · Cells · doi:10.3390/cells8080925 · Cited by 27
“In the early phase of DR (or non-PDR), high blood sugar activates several complex interconnecting pathways including those producing pro-angiogenic and inflammatory factors that play a prominent role in increasing vascular permeability [13].”
BackgroundSpecialized pro-resolving mediators in diabetes: novel therapeutic strategies
Brennan, E. P., Mohan, M., Andrews, D. C., Bose, M., & Kantharidis, P. (2019) · Clinical Science · doi:10.1042/cs20190067 · Cited by 30
Aires, I. D., Madeira, M. H., Boia, R., Rodrigues‐Neves, A. C., Martins, J., Ambrósio, A. F., & Santiago, A. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-53627-y · Cited by 29
Of neurons and pericytes: The neuro-vascular approach to diabetic retinopathy
Eleftheriou, C. G., Ivanova, E., & Sagdullaev, B. T. (2020) · Visual Neuroscience · doi:10.1017/s0952523820000048 · Cited by 28
“…(Lieth et al., 1998; Catalani et al., 2007; Gowda et al., 2011), leading to further physiological disruptions such as oxidative stress, inflammation (Smith, 2002; Krady et al., 2005; Simo et al., 2014; Rubsam et al., 2018), and neuronal apoptosis (Barber et al., 1998; Kern & Barber, 2008).”
BackgroundHuang, Q., Wu, H., Wo, M., Ma, J., Song, Y., & Fei, X. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.51533 · Cited by 29
“Increasing evidence points to inflammation as a critical contributor to the development of DR [9], and many inflammatory markers are associated with increased risk of DR [10].”
Luo, R., Li, L., Xiao, F., & Fu, J. (2022) · Inflammation · doi:10.1007/s10753-022-01665-6 · Cited by 26
“Inflammation plays an integral part in DR, which is interlinked with oxidative stress, formation of advanced glycation end-products, and increased expression of vascular endothelial growth factor (VEGF) [6].”
BackgroundLiu, P., Zhang, Z., Cai, Y., Yang, Y., Yuan, J., & Chen, Q. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115336 · Cited by 26
Mao, X., Cheng, Y., & Xu, Y. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7327 · Cited by 32
“DR is a cause of blindness in individuals and affects their quality of life (23).”
BackgroundTrotta, M. C., Pieretti, G., Petrillo, F., Alessio, N., Hermenean, A. O., Maisto, R., & D’Amico, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29303 · Cited by 26
The clinical significance of long non-coding RNA ANRIL level in diabetic retinopathy
Chen, S., Zhong, H., Wāng, Y., Wang, Z., Liang, X., Li, S., Li, Z., Yu, Z., Li, L., Yi, G., et al. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01442-2 · Cited by 25
Fiori, A., Hammes, H., & Bieback, K. (2020) · Cytotherapy · doi:10.1016/j.jcyt.2020.02.005 · Cited by 26
Diabetic Retinopathy, a Comprehensive Overview on Pathophysiology and Relevant Experimental Models
Gettinger, K., Lee, D., Tomita, Y., Negishi, K., & Kurihara, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209882 · Cited by 37
“Retinal ischemia initiates many of the aforementioned inflammatory changes, such as VEGF expression and increased cytokine production, and therefore is usually seen in conjunction with inflammation [64,65].”
Role of interferons in diabetic retinopathy
Li, B., Tan, W., Zou, J., He, Y., Yoshida, S., Jiang, B., & Zhou, Y. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i7.939 · Cited by 25
Rasoulinejad, S. A., Akbari, A., & Nasiri, K. (2021) · PubMed Central · doi:10.22038/ijbms.2021.56958.12706 · Cited by 24
“Furthermore, our results showed that the level of MIP-1α significantly increased in the eye tissue of diabetic rats which is consistent with previous studies (36).”
ResultRiemann, C. D., Eaton, A. M., & Cutino, A. (2020) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20200501-09 · Cited by 24
Boyer, D. S., Rippmann, J. F., Ehrlich, M. S., Bakker, R. A., Chong, V. N., & Nguyen, Q. D. (2021) · International Journal of Retina and Vitreous · doi:10.1186/s40942-021-00288-7 · Cited by 23
“Müller glial cells are a significant source of inflammatory modulators, suggesting that retinal glial cell activation may play an early role in the onset of inflammatory processes that damage the retina as the disease progresses [50].”
BackgroundRecent Advancements in the Medical Treatment of Diabetic Retinal Disease
Szymanska, M., Mahmood, D., Yap, T. E., & Cordeiro, M. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179441 · Cited by 30
“Elevated levels of various proinflammatory cytokines such as tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β), and IL-6 and chemokines such as monocyte chemoattractant protein 1 (MCP-1), CCL2, and CCL5 have been found in the DR eyes [28].”
BackgroundYan, A., Zhang, Y., Wang, X., Cui, Y., & Tan, W. (2022) · Bioengineered · doi:10.1080/21655979.2022.2080367 · Cited by 23
“Emerging evidence has shown that inflammation functions as a key player in DR, especially PDR [17].”
BackgroundRetractedMiR-200c-3p regulates pyroptosis by targeting SLC30A7 in diabetic retinopathy
Li, W., Yang, S., Chen, G., & He, S. (2022) · Human & Experimental Toxicology · doi:10.1177/09603271221099589 · Cited by 23
“These results suggest that inhibiting miR-200c-3p mitigates pyroptosis in DR. Studies have shown that miRNAs have an important effect on gene expression by regulating transcriptional translation and may be involved in regulating the progression of a variety of diseases, including DR.25 Yan et al. suggest that miRNA-45…”
BackgroundInfluentialInvolvement of transient receptor potential channels in ocular diseases: a narrative review
Yang, T., Yu, Y., Yang, H. J., Li, J.-J., Zhu, J., Vieira, J. A. C., & Jiang, Q. L. (2022) · Annals of Translational Medicine · doi:10.21037/atm-21-6145 · Cited by 22
“Dyslipidemia, angiogenic, inflammatory, oxidative stress, and extracellular matrix pathways are implicated in the pathogenesis of DR (187,188).”
Albalawi, F. E., Alsharif, I., Moawadh, M. S., Alkhoshaiban, A., Alshehri, F. F., Albalawi, A. E., Althobaiti, N. A., Alharbi, Z. M., & Almohaimeed, H. M. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112021 · Cited by 24
Chung, Y.-R., Lee, S. Y., Kim, Y. H., Byeon, H.-E., Kim, J. H., & Lee, K. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01495-8 · Cited by 23
Kąpa, M., Koryciarz, I., Kustosik, N., Jurowski, P., & Pniakowska, Z. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030683 · Cited by 25
The role of gut microbiota dysbiosis in the inflammatory pathogenesis of diabetic retinopathy
Xie, L., & Lin, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1604315 · Cited by 28
CNTF Prevents Development of Outer Retinal Neovascularization Through Upregulation of CxCl10
Bucher, F., Aguilar, E., Marra, K. V., Rapp, J., Arnold, J., Diaz‐Aguilar, M. S., Lange, C., Agostini, H. T., Schlunck, G., Stahl, A., et al. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.10.20 · Cited by 22
Wang, Y., Liu, X., Zhu, L., Li, W., Li, Z., Lu, X.-T., Liu, J., Hua, W., Zhou, Y., Gu, Y., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.134 · Cited by 23
Endothelial cell CD36 deficiency prevents normal angiogenesis and vascular repair.
Khzam, L. B., Son, N.-H., Mullick, A. E., Abumrad, N. A., & Goldberg, I. J. (2020) · American Journal of Translational Research · Cited by 29
Mannino, G., Longo, A., Gennuso, F., Anfuso, C. D., Lupo, G., Giurdanella, G., Giuffrida, R., & Furno, D. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094604 · Cited by 30
“In response to increased oxidative stress, MMP9 increases vascular permeability by disrupting the tight junction complex [39,40].”
BackgroundInfluentialSmith, J. M., Mandava, N., Tirado, V., García‐Santisteban, R., Geiger, M. D., Patnaik, J. L., Frazer‐Abel, A. A., Lynch, A. M., Mandava, N., Holers, V. M., et al. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.4.13 · Cited by 24
Shityakov, S., Nagai, M., Ergün, S., Braunger, B. M., & Förster, C. Y. (2022) · Biomolecules · doi:10.3390/biom12081113 · Cited by 24
Relationship Between Estimated Glucose Disposal Rate and Type 2 Diabetic Retinopathy
Meng, C., Xing, Y., Huo, L., & Ma, H. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s395818 · Cited by 27
Blot, G., Karadayi, R., Przegralek, L., Sartoris, T.-M., Charles‐Messance, H., Augustin, S., Négrier, P., Blond, F., Muñiz-Ruvalcaba, F. P., la Parra, D. R.-D., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci161348 · Cited by 29
“Early PA stimulation upregulated the expression of the cytokines CCL2, FGF2, GMCSF, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IFN-γ, and TNF-α, which have been found to be elevated in the vitreous of patients with DR (5).”
Xue, L., Hu, M., Zhu, Q., Li, Y., Zhou, G., Zhang, X., Zhou, Y., Zhang, J., & Ding, P. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08895-3 · Cited by 22
Lipocalin-2 as a mediator of neuroimmune communication.
Afridi, R., Kim, J.-H., Bhusal, A., Lee, W.-H., & Suk, K. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad157 · Cited by 21
von Schulthess, E. L., Maunz, A., Chakravarthy, U., Holekamp, N. M., Pauleikhoff, D., Patel, K., Bachmeier, I., Yu, S., Cohen, Y., Parian-Scherb, M., et al. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.5.26 · Cited by 22
Yang, J., Yang, K., Meng, X., Liu, P., Fu, Y., & Wang, Y. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s299010 · Cited by 22
“SNHG1 might play a significant role in the pathogenesis of DR.”
BackgroundInfluentialUrolithin A ameliorates diabetic retinopathy via activation of the Nrf2/HO-1 pathway
Xu, Z., Li, S., Li, K., Wang, X., Li, X., An, M., Yu, X., Long, X., Zhong, R., Liu, Q., et al. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej21-0490 · Cited by 23
“UA represses the inflammatory reactions and oxidative stress caused by HG in HRECs It is widely accepted that both inflammation and oxi‐ dative damage play pivotal roles in DR progression [15, 35].”
BackgroundAqueous Humor Cytokines in Non-Proliferative Diabetic Retinopathy
Obadă, O., Pantalon, A. D., Rusu-Zota, G., Hăisan, A., Lupuşoru, S. I., Constantinescu, D., & Chiseliţă, D. (2022) · Medicina · doi:10.3390/medicina58070909 · Cited by 21
“MCP-1 is involved in leukostasis and attracting macrophages into areas with low perfusion [30], and high levels of both AH and VH are correlated with DME [27].”
BackgroundGiblin, M. J., Ontko, C. D., & Penn, J. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-12683-7 · Cited by 26
System-wide vitreous proteome dissection reveals impaired sheddase activity in diabetic retinopathy
Shaik, A. A., Qiu, B., Lai, S. L., Cheung, N., Tan, G. S. W., Neo, S. P., Tan, A., Cheung, C. M. G., Hong, W., Wong, T. Y., et al. (2022) · Theranostics · doi:10.7150/thno.72947 · Cited by 23
“Chronic retinal inflammation is one of the prime pathogenic factors in DR causing both neuronal and vascular damage, and several studies have shown infiltration by circulating immune cells promoting such a degenerative response [62].”
BackgroundKarami, F., Jamaati, H., Coleman‐Fuller, N., Zeini, M. S., Hayes, A. W., Gholami, M., Salehirad, M., Darabi, M., & Motaghinejad, M. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00469-1 · Cited by 21
Ding, R., Zeng, Y., Wei, Z., He, Z., Jiang, Z., Yu, J., & You, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1356929 · Cited by 25
Micro‐ RNAs in the aqueous humour of patients with diabetic macular oedema
Cho, H., Hwang, M., Hong, E. H., Yu, H. S., Park, H., Koh, S., & Shin, Y. U. (2020) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13750 · Cited by 21
“Only two cytokines (VEGF and IL-6) are known to play key roles in DMO pathogenesis, and this is consistent with our bioinformatics results.(39,48,49) The reason for this difference may be that we used different samples for each of the miRNA and cytokine studies because the amount of sampled fluid was too small to carr…”
ResultCouturier, A., Blot, G., Vignaud, L., Nanteau, C., Slembrouck-Brec, A., Fradot, V., Acar, N., Sahel, J., Tadayoni, R., Thuret, G., et al. (2021) · Glia · doi:10.1002/glia.23983 · Cited by 27
Huang, H.-W., Yang, C., & Yang, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137233 · Cited by 23
“These cytokines and chemokines participate in the development of diabetic retinal disease [25].”
BackgroundAdvancing Diabetic Retinopathy Research: Analysis of the Neurovascular Unit in Zebrafish
Middel, C. S., Hammes, H., & Krøll, J. (2021) · Cells · doi:10.3390/cells10061313 · Cited by 23
“In all, 90% of retinal glia are Müller cells [84].”
BackgroundInfluentialTabari, M. A. K., Mirjalili, R., Khoshhal, H., Shokouh, E., Khandan, M., Hasheminasabgorji, E., Hafezi‐Moghadam, A., & Bagheri, A. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4708527 · Cited by 22
“And the accumulation of these cytokines increases the apoptosis of neurons in the retina [93].”
BackgroundXu, Y., Zhang, S., Zhang, S., Yang, M., Zhao, X. J., Sun, M.-Z., & Feng, X. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113791 · Cited by 19
Khoramnia, R., Pető, T., Koch, F., Taylor, S. R. J., Sousa, J. P. C., Hill, L., Bailey, C., & Chakravarthy, U. (2022) · British Journal of Ophthalmology · doi:10.1136/bjo-2022-321415 · Cited by 20
Hong, L., Lin, Y., Yang, X., Wu, T., Zhang, Y., Xie, Z., Yu, J., Zhao, H., Yi, G., & Fu, M. (2022) · Ophthalmology and Therapy · doi:10.1007/s40123-022-00581-0 · Cited by 24
“The occurrence of inflammation has been shown to precede the appearance of microvascular pathological changes [78].”
BackgroundWang, J., Wei, F., Wang, Y., Liu, Q., He, R.-X., Huang, Y., Wei, K., Xie, X., & Zhang, M. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.116131 · Cited by 21
Targeting the Mitochondrial Chaperone TRAP1 Alleviates Vascular Pathologies in Ischemic Retinopathy
Kim, S., Yoon, N. G., Im, J. Y., Lee, J. H., Kim, J., Jeon, Y., Choi, Y. J., Lee, J., Uemura, A., Park, D. H., et al. (2023) · Advanced Science · doi:10.1002/advs.202302776 · Cited by 24
Yang, X., Cao, J., Du, Y., Gong, Q., Cheng, Y., & Su, G. (2019) · Medical Science Monitor · doi:10.12659/msm.915748 · Cited by 21
Choroidal and retinal structural, cellular and vascular changes in a rat model of Type 2 diabetes
Campos, A., Martins, J., Campos, E. J., da Silva, R. M., & Ambrósio, A. F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110811 · Cited by 21
“Those facts pointed DR to be an inflammatory condition and that was confirmed experimentally [8,9].”
BackgroundBahr, H. I., Abdelghany, A. A., Galhom, R. A., Barakat, B. M., Arafa, E. A., & Fawzy, M. S. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.107742 · Cited by 20
Li, Y., Duan, B., Li, Y., Yu, S., & Wang, Y. (2020) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2020.1782426 · Cited by 21
“TNF-a, and IL-6) in the maternal, placental, and fetal compartments [21,22].”
BackgroundUnveiling the role of polyphenols in diabetic retinopathy
Behl, T., Kumar, K., Singh, S., Sehgal, A., Sachdeva, M., Bhatia, S., Al‐Harrasi, A., Buhaș, C. L., Pusta, C. T. J., Negruţ, N., et al. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104608 · Cited by 19
Ko, G. Y. ‐., Yu, F., Bayless, K. J., & Ko, M. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012099 · Cited by 20
“Increased activities of caspase-3 and -8 indicate an increase of cell apoptosis, and upregulations of ICAM-1 and VCAM-1 induce leukostasis (adherence of leukocytes) in the retinal vessels and promote further inflammatory reactions by mediating the migration of leukocytes [80].”
BackgroundPotential Protective Function of Adiponectin in Diabetic Retinopathy
Deng, H., Ai, M., Cao, Y., Cai, L., Xi, G., Yang, X., Yi, G., & Fu, M. (2023) · Ophthalmology and Therapy · doi:10.1007/s40123-023-00702-3 · Cited by 20
“The neuroretina’s aberrant thickening due to fluid accumulation, frequently accompanied by macular cystoid edema, is the most common cause of vision loss in patients with DR [108].”
BackgroundHomeostasis and dyshomeostasis of the retina
Zhang, C.-J., & Jin, Z. (2023) · Current Medicine · doi:10.1007/s44194-023-00021-6 · Cited by 28
Jiang, M., Wang, X., Wang, P., Peng, W., Zhang, B., & Guo, L. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11422 · Cited by 21
de Lemos, L., Antas, P., Ferreira, I. S., Santos, I. P., Felgueiras, B., Gomes, C. M., Brito, C., Seabra, M. C., & Tenreiro, S. (2024) · In vitro models · doi:10.1007/s44164-024-00068-1 · Cited by 24
“These cells could be responsible for the production and secretion of several inflammatory mediators including VEGF, MCP-1, tumour necrosis factor-α (TNF-α), IL-1β, and interleukin-6 (IL-6) [59].”
Dierschke, S. K., Toro, A. L., Miller, W. P., Sunilkumar, S., & Dennis, M. D. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013711 · Cited by 18
“Retinal inflammation plays a critical role in the pathogenesis of diabetic retinopathy (DR) (1, 2).”
BackgroundKir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review)
Li, X., Lv, J., Li, J., & Ren, X. S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10453 · Cited by 23
Diabetes mellitus associated neurovascular lesions in the retina and brain: A review
Sinclair, S. H., Miller, E. S., Talekar, K. S., & Schwartz, S. S. (2022) · Frontiers in Ophthalmology · doi:10.3389/fopht.2022.1012804 · Cited by 22
Sadikan, M. Z., Nasir, N. A. A., Bakar, N. S., Iezhitsa, I. N., & Agarwal, R. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04005-9 · Cited by 22
“IFN-γ also independently stimulates VEGF expression in retinal pigment epithelial cells via the PI-3 K/ Akt/mTOR/p70 S6 kinase pathway [93].”
BackgroundInfluentialMicroRNA 9 Is a Regulator of Endothelial to Mesenchymal Transition in Diabetic Retinopathy
Wang, E., Feng, B., & Chakrabarti, S. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.7.13 · Cited by 21
“7,9,11,71 The importance of EndMT in various aspects of DR is not fully understood.”
Chen, X., Zhao, J., You, Y., Li, Z., & Chen, S. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s407391 · Cited by 20
“The pathogenesis of DR is not fully understood, and is currently thought to be related to abnormal metabolic pathways, oxidative stress and inflammation.(17,18) Among them, chronic inflammation is a key factor in the development of DR.”
BackgroundMcCurry, C. M., Sunilkumar, S., SUBRAHMANIAN, S. M., Yerlikaya, E. I., Toro, A. L., VanCleave, A. M., Stevens, S. A., Barber, A. J., Sundstrom, J., & Dennis, M. D. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.3.34 · Cited by 18
Deuchler, S., Schubert, R., Singh, P. K., Chedid, A., Brui, N., Kenikstul, N., Kohnen, T., Ackermann, H., & Koch, F. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248439 · Cited by 18
“It is unclear why this occurs in the later stages of the disease [13]; however, it has been observed in patients with hyperfluorescent DME [18,19].”
BackgroundResultZeng, Q., Luo, Y., Fang, J., Xu, S., Hu, Y.-H., & Yin, M. (2021) · European Journal of Ophthalmology · doi:10.1177/11206721211020200 · Cited by 19
Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema
Mateos-Olivares, M., García‐Onrubia, L., Valentín-Bravo, F. J., González‐Sarmiento, R., López-Gálvez, M., Jimeno, J. C. P., Usategui‐Martín, R., & Pastor‐Idoate, S. (2021) · Cells · doi:10.3390/cells10071683 · Cited by 21
“The upregulation of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) is a good case in point [3,11,56].”
BackgroundSunilkumar, S., Toro, A. L., McCurry, C. M., VanCleave, A. M., Stevens, S. A., Miller, W. P., Kimball, S. R., & Dennis, M. D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102638 · Cited by 19
“Retinal Müller glia play a central role in the development of inflammation in DR (2).”
BackgroundXi, X., Chen, Q., Ma, J., Wang, X., Zhang, Y., Xiong, Q., Liu, X., Xia, Y., & Li, Y. (2025) · MedComm · doi:10.1002/mco2.70351 · Cited by 25
Campos, A., Campos, E. J., Martins, J., Rodrigues, F. S. C., da Silva, R. M., & Ambrósio, A. F. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108195 · Cited by 18
Galvão, F. M., Silva, Y. P., de Resende, M. I. L., Barbosa, F. R., Martins, T. A., & Carneiro, L. B. (2021) · Revista Brasileira de Oftalmologia · doi:10.37039/1982.8551.20210006 · Cited by 22
Zhao, H., & He, Y. (2021) · Journal of Immunology Research · doi:10.1155/2021/2389029 · Cited by 25
Zhu, M., Li, N., Wang, Y., Gao, S., Wang, J., & Shen, X. P. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03622-z · Cited by 22
“After antiVEGF therapy, there was a statistically remarkable reduction of inflammation-associated cytokines in serum and aqueous (Mizutani et al.1998; El-Asrar et al. 2004; Rübsam et al. 2018), and then improve the function of the blood-retinal barrier (BRB), but the detailed mechanisms during this process are not yet…”
BackgroundMechanistic insights into the role of FOXO in diabetic retinopathy.
Behl, T., Wadhwa, M., Sehgal, A., Singh, S., Sharma, N., Bhatia, S., Al‐Harrasi, A., Aleya, L., & BUNGAU, S. G. (2022) · PubMed · Cited by 21
O-GlcNAc Modification and Its Role in Diabetic Retinopathy
Liu, C., Dong, W., Li, J., Kong, Y., & Ren, X. S. (2022) · Metabolites · doi:10.3390/metabo12080725 · Cited by 21
“Multiple factors can lead to the occurrence and development of DR, including increased polyol-pathway activity [9], protein kinase C activation [10], oxidative stress [11], and inflammatory response [12].”
BackgroundChong, V. N., Nguyen, Q. D., Sepah, Y. J., Giani, A., & Pearce, E. (2022) · Trials · doi:10.1186/s13063-022-06527-y · Cited by 16
Physical Activity Status and Diabetic Retinopathy: A Review
AlQabandi, Y., Nandula, S. A., Boddepalli, C. S., Gutlapalli, S. D., Lavu, V. K., Abdelwahab, R. A. M., Huang, R., Potla, S., Bhalla, S., & Hamid, P. (2022) · Cureus · doi:10.7759/cureus.28238 · Cited by 25
“They found that moderate-tovigorous physical activity was inversely associated with systematic inflammation among retinopathy patients, knowing that increased inflammation could increase the severity of retinopathy [44].”
BackgroundBhutia, C. U., Kaur, P., Singh, K., & Kaur, S. (2023) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_345_23 · Cited by 17
“As a consequence, characteristic changes develop, which include exudates, microaneurysms, hemorrhages, and retinal edema.[2,3] Biomarkers are molecules found in blood or other body fluids and tissues that help in identifying individuals who are at higher risk for developing the disease and for monitoring disease progr…”
BackgroundSong, Y., Lv, P., & Yu, J. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14419 · Cited by 17
“Besides, increasing evidence points to inflammation as one key player in DR (Lv et al., 2019; Rubsam et al., 2018; Tang & Kern, 2011).”
BackgroundThe Role of Immune Cells and Signaling Pathways in Diabetic Eye Disease: A Comprehensive Review
Barone, V., Surico, P. L., Cutrupi, F., Mori, T., Afflitto, G. G., Zazzo, A. D., & Coassin, M. (2024) · Biomedicines · doi:10.3390/biomedicines12102346 · Cited by 22
“The pathogenesis of DME shares many mechanisms with DR, and particularly the vascular damage driven by hyperglycemia, inflammation, oxidative stress, and neurodegeneration [30,48].”
BackgroundKhan, R., Ooi, X. Y., Parvus, M. N., Valdez, L., & Tsin, A. T. C. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89408 · Cited by 24
Simonsen, J. R., Järvinen, A., Hietala, K., Harjutsalo, V., Forsblom, C. M., Groop, P., & Lehto, M. J. (2020) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-316202 · Cited by 21
Yang, B. J., Ma, G., & Liu, Y. (2020) · Medical Science Monitor · doi:10.12659/msm.925087 · Cited by 18
Severity of Disorganization of Retinal Layers and Visual Function Impairment in Diabetic Retinopathy
Vujosevic, S., Alovisi, C., Piccoli, G., Brambilla, M., Torti, E., Marenzi, E., Leporati, F., Luzi, L., & Nucci, P. (2024) · Ophthalmology Retina · doi:10.1016/j.oret.2024.04.005 · Cited by 16
Zhang, W., Zhang, D., Cheng, Y., Liang, X., & Wang, J. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.108969 · Cited by 17
Itam, A. H., Kuo, Y., Abubakar, A. N., Lawal, B., Agboola, A. R., Lukman, H. Y., Onikanni, S. A., Olawale, F., Fadaka, A. O., Ibrahim, Y. O., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114114 · Cited by 18
RetractedQiu, A.-W., Wang, N., Yin, W.-J., Zhu, Z.-Q., Liu, Q., & Zhang, W.-W. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.1.1 · Cited by 16
Liu, X., & Cui, H. (2021) · Bioengineered · doi:10.1080/21655979.2021.2003924 · Cited by 16
“Multifactors including end products of glycosylation, inflammation [3], cytokines and chemokines [4], disruption of proliferator-activated receptor [5], growth factors [6] as well as oxidative stress [7,8] have been implicated in the pathophysiology of diabetic retinopathy.”
BackgroundUnconventional avenues to decelerate diabetic retinopathy
Takkar, B., Sheemar, A., Jayasudha, R., Soni, D., Narayanan, R., Venkatesh, P., Shivaji, S., & Das, T. (2022) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2022.06.004 · Cited by 18
Gong, Q., Yu, S., Qian, T., & Xu, X. (2022) · International Journal of Ophthalmology · doi:10.18240/ijo.2022.11.02 · Cited by 22
Lamy, R., Farber-Katz, S., Vives, F., Ayanoglu, G., Zhao, T., Chen, Y., Laotaweerungsawat, S., Ma, D., Phone, A., Psaras, C., et al. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.10.3 · Cited by 17
Association of sleep disturbance with diabetic retinopathy
Dutta, S., Ghosh, S., & Ghosh, S. (2020) · European Journal of Ophthalmology · doi:10.1177/1120672120974296 · Cited by 20
Liu, S., Chen, C., Ning, J., Ding, P., Chen, Y., Xie, T., Yang, H., Yan, X., & Han, J. (2025) · Visual Neuroscience · doi:10.48130/vns-0025-0012 · Cited by 27
Biological Characteristics of Subsilicone Oil Fluid and Differences With Other Ocular Humors
Shimizu, H., Kaneko, H., Suzumura, A., Takayama, K., Namba, R., Funahashi, Y., Kataoka, K., Iwase, T., Hwang, S.-J., Ito, S., et al. (2019) · Translational Vision Science & Technology · doi:10.1167/tvst.8.1.28 · Cited by 16
Chen, H., Yan, T., Song, Z., Ying, S., Wu, B., Ju, X., Yang, X., Qu, J., Wu, W., Zhang, Z., et al. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00607-w · Cited by 17
Metadata
- Authors
- Rübsam, A., Parikh, S., & Fort, P.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Fort, Patrice
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-03-22
- Volume
- 19
- Issue
- 4
- Pages
- 942
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5979417
- OpenAlex
- W2793401320
- Cited by
- 750
- References
- 249
- Citations by year
- 2026: 46 · 2025: 91 · 2024: 107 · 2023: 118 · 2022: 127 · 2021: 107 · 2020: 83 · 2019: 59 · 2018: 11
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Eye Institute (R01-EY020895)
- Deutsche Forschungsgemeinschaft (RU 2020/2-1)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- diabetic retinopathy, inflammation, neuroglial interactions, retinal microvasculature, oxidative stress, advanced glycation end products, vascular endothelial growth factor, glial cells, neurons, diabetes complications
- MeSH terms
- Animals, Astrocytes, Diabetic Retinopathy, Humans, Inflammation, Neurodegenerative Diseases, Ependymoglial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.